Swiss National Bank - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$250,000
-59.8%
201,9000.0%0.00%
-100.0%
Q1 2017$622,000
-24.5%
201,9000.0%0.00%0.0%
Q4 2016$824,000
-30.1%
201,900
+8.8%
0.00%
-50.0%
Q3 2016$1,179,000
+17.9%
185,6000.0%0.00%0.0%
Q2 2016$1,000,000
-29.7%
185,600
+5.5%
0.00%
-33.3%
Q1 2016$1,423,000
+31.5%
176,000
+28.6%
0.00%0.0%
Q4 2015$1,082,000
-7.1%
136,9000.0%0.00%0.0%
Q3 2015$1,165,000
-20.1%
136,900
+16.1%
0.00%
-25.0%
Q2 2015$1,458,000
+6.5%
117,900
+2.3%
0.00%0.0%
Q1 2015$1,369,000
+8.8%
115,200
+3.5%
0.00%
-20.0%
Q4 2014$1,258,000
+28.8%
111,3000.0%0.01%
+25.0%
Q3 2014$977,000
+20.5%
111,3000.0%0.00%
+33.3%
Q2 2014$811,000
+44.6%
111,3000.0%0.00%
+50.0%
Q1 2014$561,000
+13.8%
111,300
+20.5%
0.00%0.0%
Q4 2013$493,000
+40.5%
92,4000.0%0.00%
+100.0%
Q3 2013$351,000
-39.2%
92,400
+7.7%
0.00%
-66.7%
Q2 2013$577,00085,8000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders